Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab - Phase 2
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• 18 years of age or older
• Able to speak and read in English
• Actively receiving Trastuzumab or an anthracycline-based treatment
• Currently receiving immunotherapy. This includes pembrolizumab and atezolizumab.
• Diagnosed with stages 0-III Breast Cancer
Locations
United States
Virginia
Adult Outpatient Pavilion
RECRUITING
Richmond
Cellular Immunotherapies and Transplant Department
RECRUITING
Richmond
VCU Health at Stony Point
RECRUITING
Richmond
Contact Information
Primary
Arnethea Sutton, Ph.D
careslab@vcu.edu
8048277363
Backup
Victoria Williams
williamsv4@vcu.edu
8048277363
Time Frame
Start Date: 2026-05-20
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 30
Treatments
Experimental: Virtual Reality Group
Individuals in this arm will receive access to the virtual reality in cardiovascular health education and gaming intervention
Related Therapeutic Areas
Sponsors
Leads: Virginia Commonwealth University